Protective Effects of Rivaroxaban on White Matter Integrity and Remyelination in a Mouse Model of Alzheimer’s Disease Combined with Cerebral Hypoperfusion
Zhihong Bian(Okayama University), Toru Yamashita(Okayama University)
Cited by 3
Related Papers
Single-institution experience with efgartigimod in patients with GFAP astrocytopathy: Treatment response and adverse events
|Multiple Sclerosis and Related Disorders|2026|1